NCBI PubMed Centralopen access
Mesenchymal stem cell-induced metabolic reprogramming of EGFR-wild-type tumor cells drives therapeutic resistance in EGFR-mutant non-small cell lung cancer.
distributed systems architecture
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 480979
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.